Jenburkt Pharmaceuticals Ltd — Insider Trading, 15-12-2025: Insider Trading / SAST

Jenburkt Pharmaceuticals has announced the closure of its trading window for designated persons, insiders, and their relatives. This action, starting January 1, will last until 48 hours after the financial results for the quarter and nine months are publicly disseminated. The company will separately announce a board meeting to review these upcoming financial results. This measure ensures market fairness by preventing individuals with access to price-sensitive information from trading ahead of its public release, protecting investor interests.